{"podcast":{"title":"Detroit News Today  | 2 Min News | The Daily News Now!","slug":"detroit-news-today-2-min-news-the-daily-news-now-7476185","podcast_index_feed_id":7476185,"rss_url":"https://feeds.fastcast.ai/the-detroit-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-detroit-daily-news-now.jpg","author":"The Daily News Now!","episode_count":784,"summary":"Hosted by Corey with the Story, Detroit News Today delivers fast, focused daily updates on the stories shaping Detroit—from local news and business to culture, sports, and community developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local news to every city in the world and keeping communities connected. Detroit News Today is your daily snapshot of what’s happening across the city. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-09-19T00:23:32.826844+00:00","page_url":"https://stenobird.com/podcast/detroit-news-today-2-min-news-the-daily-news-now-7476185"},"episode":{"title":"New Pill Targets Resistant Breast Cancer | Detroit News","slug":"new-pill-targets-resistant-breast-cancer-detroit-news","published_at":"2026-09-11T19:00:58+00:00","page_url":"https://stenobird.com/podcast/detroit-news-today-2-min-news-the-daily-news-now-7476185/new-pill-targets-resistant-breast-cancer-detroit-news","show_page_url":"https://stenobird.com/podcast/detroit-news-today-2-min-news-the-daily-news-now-7476185","url":"https://sources.thednn.ai/532ca3f8355edcbf","audio_url":"https://api.fastcast.ai/audio/e716b222-8b06-4210-92b8-2c328bd86b91.mp3","summary":"A breakthrough pill called Etcamah is showing promise for advanced estrogen-driven breast cancer that resists standard treatments. Designed to target specific genetic mutations—like those in the ESR1 gene—that let cancer cells evade therapy, it’s paired with a revolutionary blood test that spots resistance before scans can detect it. This early intervention could dramatically improve outcomes. The FDA has granted accelerated approval based on its ability to delay disease progression, though longer-term survival data is still pending. For patients with treatment-resistant cancer, this could be a major new weapon in the fight. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/532ca3f8355edcbf","meta_description":"A breakthrough pill called Etcamah is showing promise for advanced estrogen-driven breast cancer that resists standard treatments. Designed to target spec…","key_points":[],"chapters":[],"topics":[],"duration_seconds":100,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/detroit-news-today-2-min-news-the-daily-news-now-7476185/episodes/new-pill-targets-resistant-breast-cancer-detroit-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/detroit-news-today-2-min-news-the-daily-news-now-7476185/new-pill-targets-resistant-breast-cancer-detroit-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}